This website uses cookies to ensure you get the best experience
NR-2 Ab ELISA
NR-2 Ab ELISA is a test kit intended for quantitative detection of antibodies to NR2, a biomarker associated with cerebral ischemia. The test is intended to aid in the assessment of chronic cerebral ischemia and to aid in identifying patients at increased risk of near-term ischemic stroke.
Predictive Biomarker
Elevated NR2 antibody levels reliably predict increased risk of near-term ischemic stroke or Transient Ischemic Attacks (TIAs), providing essential information for proactive patient management
User-friendly and Efficient
Designed for straight forward laboratory implementation with clear instructions, standardized controls, and streamlined assay procedure
High Sensitivity and Precision
Demonstrates a low detection limit (0.7 ng/mL) and excellent precision, ensuring reliable and reproducible results
Clinically Validated
Supported by multiple scientific studies and clinical trials confirming its efficacy and clinical relevance as a stroke biomarker
Robust and Specific
Exhibits no cross‐reactivity with other common neurological antigens, ensuring high specificity and accuracy in detecting antibodies to the NR2 subunit